Evolent Health (NYSE:EVH) Trading Up 12.4% - Should You Buy?

Key Points

• Evolent Health's shares increased by 12.4% to $9.43, despite a significant decline in trading volume of 88% from its average.
• Analysts have set a consensus target price of $17.21, with varied ratings including strong buys and neutral holds from multiple firms.
• The company reported a quarterly loss of ($0.10) EPS, missing expectations and showing a 31.3% decline in revenue compared to the previous year.

Evolent Health, Inc (NYSE:EVH - Get Free Report)'s share price was up 12.4% during trading on Wednesday . The company traded as high as $9.19 and last traded at $9.43. Approximately 332,295 shares changed hands during trading, a decline of 88% from the average daily volume of 2,692,721 shares. The stock had previously closed at $8.39.

Analysts Set New Price Targets

A number of equities analysts have recently commented on EVH shares. JMP Securities reissued a "market outperform" rating and set a $13.00 price objective on shares of Evolent Health in a research report on Friday, June 20th. Truist Financial boosted their price objective on Evolent Health from $14.00 to $16.00 and gave the stock a "buy" rating in a research report on Thursday, July 17th. Canaccord Genuity Group reissued a "buy" rating and set a $16.00 price objective on shares of Evolent Health in a research report on Tuesday, September 9th. Piper Sandler boosted their target price on Evolent Health from $16.00 to $18.00 and gave the stock an "overweight" rating in a research note on Thursday, August 28th. Finally, Stephens restated an "equal weight" rating and set a $9.00 target price on shares of Evolent Health in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of "Buy" and a consensus target price of $17.21.

Evolent Health Stock Performance

The company has a debt-to-equity ratio of 0.72, a current ratio of 1.01 and a quick ratio of 1.01. The stock has a 50 day simple moving average of $9.42 and a two-hundred day simple moving average of $9.48. The company has a market cap of $1.09 billion, a PE ratio of -5.75 and a beta of 0.73.

Evolent Health (NYSE:EVH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The technology company reported ($0.10) earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.20). Evolent Health had a negative net margin of 5.94% and a positive return on equity of 1.83%. The firm had revenue of $444.33 million during the quarter, compared to analysts' expectations of $459.43 million. During the same quarter in the prior year, the firm posted $0.30 EPS. Evolent Health's quarterly revenue was down 31.3% compared to the same quarter last year. Evolent Health has set its Q3 2025 guidance at EPS. Equities analysts predict that Evolent Health, Inc will post 0.08 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC increased its holdings in shares of Evolent Health by 88.0% in the second quarter. Nisa Investment Advisors LLC now owns 2,551 shares of the technology company's stock valued at $29,000 after purchasing an additional 1,194 shares during the period. Banque Cantonale Vaudoise acquired a new position in shares of Evolent Health in the first quarter valued at approximately $25,000. Parallel Advisors LLC increased its holdings in shares of Evolent Health by 82.6% in the second quarter. Parallel Advisors LLC now owns 3,487 shares of the technology company's stock valued at $39,000 after purchasing an additional 1,577 shares during the period. Strs Ohio acquired a new position in shares of Evolent Health in the first quarter valued at approximately $47,000. Finally, Headlands Technologies LLC acquired a new position in shares of Evolent Health in the second quarter valued at approximately $58,000.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.